Right Drug Dose Now Act of 2025

Bill 119 hr 2471, also known as the National Action Plan for Adverse Drug Event Prevention Act, aims to update the current National Action Plan for Adverse Drug Event Prevention by incorporating advancements in pharmacogenomic research and testing. The bill seeks to improve electronic health records to better include pharmacogenomic information, which can help healthcare providers make more informed decisions about prescribing medications to patients.

The main goal of this legislation is to prevent adverse drug events, which are harmful or unintended reactions to medications. By utilizing pharmacogenomic information, healthcare providers can better understand how a patient's genetic makeup may impact their response to certain medications. This personalized approach to prescribing medications can help reduce the risk of adverse drug events and improve patient outcomes.

In addition to updating the National Action Plan, the bill also includes provisions for improving electronic health records to ensure that pharmacogenomic information is easily accessible to healthcare providers. This will help streamline the process of incorporating genetic information into medication decisions and ultimately improve patient safety. Overall, Bill 119 hr 2471 aims to leverage advancements in pharmacogenomic research and testing to enhance the prevention of adverse drug events and improve patient care. By updating the National Action Plan and improving electronic health records, this legislation seeks to promote the use of personalized medicine to optimize medication therapy and reduce the risk of harmful drug reactions.